IBIO
Income statement / Annual
Last year (2026), iBio Inc's total revenue was $100.00 K,
a decrease of 75.00% from the previous year.
In 2026, iBio Inc's net income was -$33.04 M.
See iBio Inc,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2026
|
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
| Period Ended |
06/30/2026 |
06/30/2025 |
06/30/2024 |
06/30/2023 |
06/30/2022 |
06/30/2021 |
06/30/2020 |
06/30/2019 |
06/30/2018 |
06/30/2017 |
| Operating Revenue |
$100.00 K |
$400.00 K |
$225.00 K |
$0.00 |
$1.88 M |
$2.37 M |
$1.64 M |
$2.02 M |
$444.00 K |
$394.00 K |
| Cost of Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$3.79 M
|
$1.46 M
|
$703.00 K
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit |
$100.00 K
|
$400.00 K
|
$225.00 K
|
$0.00
|
-$1.91 M
|
$909.00 K
|
$935.00 K
|
$2.02 M
|
$444.00 K
|
$394.00 K
|
| Gross Profit Ratio |
1
|
1
|
1
|
0
|
-1.01
|
0.38
|
0.57
|
1
|
1
|
1
|
| Research and Development Expenses |
$19.64 M
|
$8.31 M
|
$5.19 M
|
$10.33 M
|
$9.83 M
|
$9.99 M
|
$3.57 M
|
$5.47 M
|
$3.99 M
|
$4.12 M
|
| General & Administrative Expenses |
$10.60 M
|
$10.69 M
|
$11.67 M
|
$18.45 M
|
$0.00
|
$21.70 M
|
$11.37 M
|
$12.33 M
|
$10.69 M
|
$10.55 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$189.00 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$10.60 M
|
$10.69 M
|
$11.67 M
|
$18.45 M
|
$17.96 M
|
$21.89 M
|
$11.37 M
|
$12.33 M
|
$10.69 M
|
$10.55 M
|
| Other Expenses |
$5.00 M
|
$0.00
|
$0.00
|
$565.00 K
|
$0.00
|
$143.00 K
|
$0.00
|
$16.00 K
|
$19.00 K
|
$25.00 K
|
| Operating Expenses |
$35.24 M
|
$19.00 M
|
$16.86 M
|
$29.34 M
|
$27.79 M
|
$32.02 M
|
$14.94 M
|
$17.81 M
|
$14.67 M
|
$14.67 M
|
| Cost And Expenses |
$35.24 M
|
$19.00 M
|
$16.86 M
|
$29.34 M
|
$31.58 M
|
$33.48 M
|
$15.64 M
|
$17.81 M
|
$14.67 M
|
$14.67 M
|
| Interest Income |
$2.15 M
|
$437.00 K
|
$363.00 K
|
$213.00 K
|
$177.00 K
|
$140.00 K
|
$15.00 K
|
$75.00 K
|
$15.00 K
|
$39.00 K
|
| Interest Expense |
$53.00 K
|
$212.00 K
|
$172.00 K
|
$83.00 K
|
$1.41 M
|
$2.45 M
|
$2.47 M
|
$1.90 M
|
$1.92 M
|
$1.93 M
|
| Depreciation & Amortization |
$1.03 M
|
$1.13 M
|
$1.25 M
|
$1.38 M
|
$3.79 M
|
$2.41 M
|
$2.24 M
|
$1.75 M
|
$1.71 M
|
$1.68 M
|
| EBITDA |
-$31.96 M |
-$17.04 M |
-$14.02 M |
-$27.85 M |
-$25.72 M |
-$28.55 M |
-$11.74 M |
-$13.95 M |
-$12.48 M |
-$12.53 M |
| EBITDA Ratio |
-319.61
|
-42.6
|
-62.32
|
0
|
-13.65
|
-12.04
|
-7.17
|
-6.91
|
-28.12
|
-31.81
|
| Operating Income Ratio |
-351.41
|
-46.51
|
-73.93
|
0
|
-15.76
|
-13.12
|
-8.55
|
-7.82
|
-32.04
|
-36.23
|
| Total Other Income/Expenses Net |
$2.10 M
|
$225.00 K
|
$1.19 M
|
$32.00 K
|
$184.00 K
|
$7.90 M
|
-$2.44 M
|
-$1.81 M
|
-$1.88 M
|
-$1.87 M
|
| Income Before Tax |
-$33.04 M
|
-$18.38 M
|
-$15.44 M
|
-$29.31 M
|
-$29.51 M
|
-$23.21 M
|
-$16.44 M
|
-$17.60 M
|
-$16.11 M
|
-$14.53 M
|
| Income Before Tax Ratio |
-330.44
|
-45.94
|
-68.64
|
0
|
-15.67
|
-9.79
|
-10.04
|
-8.72
|
-36.28
|
-36.88
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
-$4.00 K
|
$34.00 K
|
$347.00 K
|
| Net Income |
-$33.04 M
|
-$18.38 M
|
-$24.91 M
|
-$65.01 M
|
-$50.39 M
|
-$23.21 M
|
-$16.44 M
|
-$17.59 M
|
-$16.11 M
|
-$14.53 M
|
| Net Income Ratio |
-330.44
|
-45.94
|
-110.7
|
0
|
-26.75
|
-9.79
|
-10.04
|
-8.72
|
-36.27
|
-36.88
|
| EPS |
-0.32 |
-1.75 |
-6.5 |
-106.18 |
-2889.06 |
-59.98 |
-304.64 |
-471.65 |
-770 |
-800 |
| EPS Diluted |
-0.32 |
-1.75 |
-6.5 |
-106.18 |
-2889.06 |
-59.98 |
-304.64 |
-471.65 |
-770 |
-800 |
| Weighted Average Shares Out |
$104.06 M
|
$10.50 M
|
$3.83 M
|
$612.25 K
|
$17.44 K
|
$391.24 K
|
$125.59 K
|
$37.85 K
|
$21.26 K
|
$17.82 K
|
| Weighted Average Shares Out Diluted |
$104.06 M
|
$10.50 M
|
$3.83 M
|
$612.25 K
|
$17.44 K
|
$391.24 K
|
$125.59 K
|
$37.85 K
|
$21.26 K
|
$17.82 K
|
| Link |
|
|
|
|
|
|
|
|
|
|
